Zulassung basiert auf der Phase-3-Studie DeLLphi-304, die eine 40-prozentige Verringerung des Sterberisikos mit IMDYLLTRA im Vergleich zur Chemotherapie nachweist Neuartige Behandlungsoption für Patienten mit fortgeschrittenem kleinzelligem Lungenkrebs im Extensivstadium THOUSAND OAKS,...
Hence then, the article about europaische kommission erteilt zulassung fur imdylltra von amgen fur die behandlung von kleinzelligem lungenkrebs im fortgeschrittenen stadium was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( EUROPÄISCHE KOMMISSION ERTEILT ZULASSUNG FÜR IMDYLLTRA® VON AMGEN FÜR DIE BEHANDLUNG VON KLEINZELLIGEM LUNGENKREBS IM FORTGESCHRITTENEN STADIUM )
Also on site :
- BURNHAM PARK CAPITAL MARKETS LAUNCHES AS CHICAGO'S NEWEST INVESTMENT BANK, WILL CONSOLIDATE FIVE SPECIALIZED FIRMS TO CREATE A FULL SERVICE PLATFORM
- Marcello Hernández to Host 2026 ESPYS
- Ueda Says BOJ Needs to Keep Raising Rates to Contain Inflation